Tweenvest Stocks

Entheon Biomedical Corp. (CNSX: ENBI.X)

Health Care · Biotechnology · CA

CA$0.06

+20.00% today · -14.3% 1Y

Entheon Biomedical Corp. (CNSX: ENBI.X) operates in the Biotechnology industry within the Health Care sector. The company is valued at $586.97K and employs 1 people.

Over the last twelve months the share price has lost 14.3%, trading between 0.04 and 0.12.

Tweenvest scores Entheon Biomedical Corp. across four factors: quality 37/100, value 41/100. Its strongest factor is value.

ENBI.X price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$586.97K
Revenue (TTM)
—
P/E
19.18
EPS
0.00
Dividend yield
—
Beta (5Y)
1.37
52-week high
CA$0.12
52-week low
CA$0.04
Avg volume (3M)
—
Shares outstanding
13.86M
Employees
1
Next earnings
—

About Entheon Biomedical Corp.

Entheon Biomedical Corp. operates as a biotechnology research and drug development company. It engages in developing and commercializing various N,N-dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. The company serves physicians, clinics, and licensed psychiatrists in Canada, the United States, and European Union. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.

ISIN
CA29383X2023
Listed since
May 3, 2018
Exchange
Canadian National Stock Exchange
Currency
CAD
CompanyMarket capPriceDay
MindBio Therapeutics Corp.CNSX: MBIO$715.26KCA$0.14-26.32%
SQZ Biotechnologies CompanyOTCPK: SQZB$707.79K$0.02-0.41%
ZyVersa Therapeutics, Inc.OTCPK: ZVSA$647.67K$0.08-19.19%
Biodexa Pharmaceuticals PlcNasdaqCM: BDRX$637.92K$0.62-8.30%
Ludwig Enterprises, Inc.OTCPK: LUDG$585.08K$0.00-65.00%
IntegraGen SAENXTPA: ALINT$519.56K€0.04-40.86%
NovelStem International Corp.OTCPK: NSTM$468.66K$0.01-7.41%
Sorrento Therapeutics, Inc.OTCPK: SRNE$434.97K$0.00+166.67%

Browse every Biotechnology company →

Figures last refreshed Oct 4, 2026.